• +971551792927
  • info-ucg@utilitarianconferences.com
Login
WhatsApp

Track 5: Heart Failure

Related Sessions

Track 1: Heart Health

About: Track 1: Cardiology Cardiology at the 5th International Heart Health & Cardiac...

Track 2: Cardiovascular Diseases

About: Track 2: Cardiovascular Diseases

 Cardiovascular Diseases at the 5th International Heart...

Track 5: Heart Failure

About: Track 5: Heart Failure

Heart failure is a medical condition where the heart is unable to pump blood effectively to meet the body's needs for oxygen and nutrients. It doesn’t mean the heart has stopped working, but rather that it is not working as efficiently as it should. As a result, the body may not receive enough blood to function properly, leading to a variety of symptoms.

Heart Failure Types | Symptoms of Heart Failure | Causes of Heart Failure | Acute vs Chronic Heart Failure | Left-sided Heart Failure | Right-sided Heart Failure | Heart Failure with Reduced Ejection Fraction (HFREF) | Heart Failure with Preserved Ejection Fraction (HFPEF) | Risk Factors for Heart Failure | Diagnosis of Heart Failure | Echocardiogram in Heart Failure | Medications for Heart Failure | Lifestyle Changes for Heart Failure | Heart Failure and Hypertension | Heart Failure and Diabetes | Heart Transplant for Heart Failure | Ventricular Assist Devices (VAD) | Cardiac Resynchronization Therapy (CRT) | Management of Heart Failure Exacerbations | Preventing Hospital Readmissions in Heart Failure

1. Diagnosis and Classification of Heart Failure

Understanding HF Subtypes

  • Heart failure with reduced ejection fraction (HFrEF)

  • Heart failure with preserved ejection fraction (HFpEF)

  • Acute versus chronic heart failure

Diagnostic Tools and Strategies

  • Role of natriuretic peptides (BNP, NT-proBNP)

  • Echocardiography and advanced cardiac imaging

  • Cardiopulmonary exercise testing and hemodynamic monitoring


2. Medical Management and Pharmacotherapy

Guideline-Directed Medical Therapy (GDMT)

  • ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists

  • ARNI therapy and SGLT2 inhibitors in HFrEF

  • Tailored therapy in HFpEF and emerging pharmacologic agents

Optimizing Therapy

  • Titration strategies and patient-specific considerations

  • Managing side effects and drug interactions

  • Addressing polypharmacy in multimorbid patients


3. Device Therapy and Advanced Interventions

Implantable Devices

  • Indications for ICDs and CRT in HF patients

  • Remote monitoring and data-driven adjustments

  • Future of smart implantable systems

Mechanical Circulatory Support (MCS)

  • Short-term and long-term LVAD use

  • Patient selection and timing of MCS

  • Transitioning patients to transplant or destination therapy